Webinar / Sep 29, 2026

Behind the Rx: How Strive Delivers Quality at Scale

Join Strive’s pharmacy experts to learn how rigorous compounding, testing, fulfillment, and compliance standards support reliable patient care nationwide.

Register Now

Personalized medicine only works when quality and compliance hold at every step. In this Strive Session, go behind the prescription to see how Strive compounds, tests, releases, and dispenses patient-specific medications nationwide.

You’ll learn what drives turnaround times and stock reliability, how sterile and non-sterile preparations are tested, and where 503A handling requirements affect your workflow. The session also covers prescriber licensing, credential security, and state-by-state considerations, giving your team practical guidance for setting expectations, protecting patients, and prescribing with confidence.

This webinar is designed for:

  • Prescribers using compounded medications across functional, integrative, longevity, or specialty care
  • Clinical leaders responsible for patient safety and operational consistency
  • Office managers and operations teams overseeing prescriptions, accounts, fulfillment, and patient communication
  • Healthcare professionals navigating 503A requirements, multi-state licensing, and controlled-substance compliance

You’ll learn how to:

  • Explain when patient-specific compounding is appropriate and how 503A dispensing differs from 503B office-use supply
  • Set accurate expectations around turnaround time, nationwide fulfillment, stock reliability, and multi-location shipping
  • Evaluate Strive’s sterile and non-sterile testing practices, including potency, sterility, endotoxin, and stability testing
  • Apply practical licensing, credential-access, and state-specific compliance considerations to everyday prescribing workflows

Content is for educational purposes and does not constitute medical or legal advice. Clinical decisions remain the responsibility of the prescriber.

Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the FDA. Statements have not been evaluated by the FDA. Availability and permissible compounding practices vary by state law.